Release Date: 01/12/17 08:43 Summary: ACCC won't seek review of Tabcorp-Tatts determination Price Sensitive: Yes Download Document 156.59KB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market